Legislation

Treaties

• Treaty on European Union and Treaty on the Functioning of the European Union
• Maastricht Treaty on European Union

International Agreements

• 31 January 1995 Agreement on illicit traffic by sea, implementing Article 17 of the UN Convention against illicit traffic in narcotic drugs and psychotropic substances
• 20 December 1988 UN Convention against the Illicit Traffic in Narcotic Drugs and Psychotropic Substances
• 21 February 1971 UN Convention on Psychotropic Substances)
• 30 March 1961 UN Single Convention on Narcotic Drugs as amended by the 1972 Protocol
• Agreement between the European Community and the Republic of Turkey on the participation of the Republic of Turkey on the EMCDDA
• Agreement between the European Community and Kingdom of Norway on the revision of the amount of the financial contribution from Norway provided for in the Agreement between the European Community and Kingdom of Norway on the participation of Norway in the work of the EMCDDA
• Declaration by the Commission of the European Communities - Agreement between the European Community and the Kingdom of Norway on the participation of Norway in the work of the EMCDDA
• Agreement between the European Community and the Kingdom of Norway on the participation of Norway in the work of the EMCDDA

Decisions

• 7 March 2013 Decision on subjecting 4-methylamphetamine to control measures
• 26 July 2010 Decision on the signing, on behalf of the Union, of the Agreement between the EU and the Republic of Croatia on the participation of the Republic of Croatia in the work of the EMCDDA
• 2 December 2010 Decision on submitting 4-methylmethcathinone (mephedrone) to control measures
• 30 November 2009 Decision setting up a European Crime Prevention Network (EUCPN) and repealing Decision of 8 June 2001 establishing a European Crime Prevention Network
• 29 April 2008 Decision concerning the conclusion of the Agreement between the European Community and the Republic of Turkey on the participation of the Republic of Turkey on the EMCDDA
• 3 March 2008 Decision on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions
• 23 October 2007 Decision establishing a second programme of Community action in the field of health (2008-13)
• 25 September 2007 Decision establishing for the period 2007-2013 the Specific Programme Drug prevention and information as part of the General Programme Fundamental Rights and Justice
• 5 June 2007 Decision on the signing of the Agreement between the European Community and the Republic of Turkey on the participation of the Republic of Turkey in the work of the EMCDDA
• 12 February 2007 Decision establishing for the period 2007 to 2013, as part of General Programme on Security and Safeguarding Liberties, the Specific Programme Prevention of and Fight against Crime
• 13 November 2006 Decision concerning the conclusion of the Agreement between the European Community and Kingdom of Norway on the revision of the amount of the financial contribution from Norway provided for in the Agreement between the European Community and Kingdom of Norway on the participation of Norway in the work of the EMCDDA
• 10 May 2005 Decision on the information exchange, risk-assessment and control of new psychoactive substances
• 25 October 2004 Framework Decision laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking
• 27 November 2003 Decision concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2
• 28 February 2002 Decision concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA
• 26 June 2001 Framework Decision on money laundering, the identification, tracing, freezing, seizing and confiscation of instrumentalities and the proceeds of crime
• 28 May 2001 Decision on the transmission of samples of controlled substances
• 28 September 2000 Decision on the conclusion of an agreement between the European Community and the Kingdom of Norway on the participation of Norway in the work of the EMCDDA
• 13 September 1999 Decision defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties

Strategies and Action Plans

• EU Drugs Strategy (2013-2020)  
• EU-Action Plan on Drugs (2009-2012)
• EU-Action Plan on Drugs (2005-2008)
• EU Drugs Strategy (2005-2012)
• EU-Action Plan on Drugs (2000-2004)
• EU Drugs Strategy (2000-2004)
• Action Plan on drugs between the EU and the Western Balkan countries (2009-2013)
• 2009-2013 Action plan on Drugs between the EU and Central Asian states
• Action-Oriented Paper Increasing EU support for combating drug production in and trafficking from Afghanistan, including transit routes
• Action Oriented Paper on implementing with Russia the Common Space of Freedom, Security and Justice

Joint Actions

• 3 December 1998 Joint Action on money laundering, the identification, tracing, freezing, seizing and confiscation of instrumentalities and the proceeds from crime
• 16 June 1997 Joint Action of concerning the information exchange, risk assessment and the control of new synthetic drugs (replaced by the Decision of 10 May 2005 )
• 9 June 1997 Joint Action for the refining of targeting criteria, selection methods, et., and collection of customs and police information
• 17 December 1996 Joint Action concerning the approximation of the laws and practices of the EU countries to combat drug addiction and to prevent and combat illegal drug trafficking
• 16 December 1996 Joint Action extending the mandate given to the Europol Drugs Unit
• 29 November 1996 Joint Action, concerning the creation and maintenance of a directory of specialized competences, skills and expertise in the fight against international organized crime, in order to facilitate law enforcement co-operation between the EU countries
• 29 November 1996 Joint Action concerning the exchange of information on the chemical profiling of drugs to facilitate improved co-operation between the EU countries in combating illicit drug trafficking
• 29 November 1996 Joint Action on co-operation between customs authorities and business organizations in combating drug trafficking
• 10 March 1995 Joint Action concerning the Europol Drugs Unit

Regulations

• 12 December 2006 Regulation on the European Monitoring Centre for Drugs and Drug Addiction (recast)

Directives

• 26 October 2005 Directive on the prevention of the use of the financial system for the purpose of money laundering and terrorist financing as amended

Recommendations

• 30 March 2004 Council Recommendation regarding guidelines for taking samples of seized drugs
• 18 June 2003 Council Recommendation on the prevention and reduction of health-related harm associated with drug dependence

Resolutions

• 13 November 2003 Council Resolution on combating the impact of psychoactive substances use on road accidents
• 12 November 2003 Council Resolution on the importance of the role of the families in preventing drug abuse by adolescents
• 15 November 2001 Council Resolution on the implementation of the five key epidemiological indicators on drugs, developed by the EMCDDA

Communications

• 15 October 2011 Communication from the Commission Towards a stronger European response to drugs
• 11 July 2011 Report from the Commission on the Assessment of the functioning of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
• 11 July 2011 Commission staff working paper on the Assessment of the functioning of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
• 5 November 2010 Report from the Commission on 2010 progress review of the EU Drugs Action Plan (2009-2012) (Annex )
• 8 October 2010 Commission staff working document on improving the collection of data on drug markets, drug-related crime and drug-supply reduction measures in the EU(132 KB)  
• 10 December 2009 Report from the Commission on the implementation of Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking
• 23 November 2009 Commission staff working document on Strengthening EU Research Capacity on Illicit Drugs(81 KB)  
• 27 July 2009 Commission staff working document on EU guidelines and mechanisms on detecting, monitoring and responding to emerging trends on drugs(61 KB)  
• 18 September 2008 Communication from the Commission on an EU Drugs Action Plan for 2009-2012
• 18 September 2008 Commission staff working document accompanying the Communication from the Commission on an EU Action Plan on Drugs (2009-2012) - Summary of the impact assessment.
• 18 September 2008 Commission staff working document accompanying the Communication from the Commission on an EU Action Plan on Drugs (2009-2012) - Impact assessment
• 18 September 2008 Commission staff working document - Accompanying document to the Communication from the Commission on an EU Drugs Action Plan (2009-2012) - Report of the final evaluation of the EU Drugs Action Plan (2005-2008)
• 10 December 2007 Communication from the Commission on the 2007 Progress Review of the implementation of the EU Drugs Action Plan (2005-2008)
• 18 April 2007 Report from the Commission on the implementation of the Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence
• 21 December 2006 Commission staff working document - 2006 - Progress Review on the implementation of the EU Drugs Action Plan (2005-2008)(360 KB)  
• 26 June 2006 GREEN PAPER on the role of Civil Society in Drugs Policy in the European Union
• 14 February 2005 Communication from the Commission on a EU Drugs Action Plan (2005-2008)
• 22 October 2004 Communication from the Commission on the results of the final evaluation of the EU Drugs Strategy and Action Plan on Drugs (2000-2004)
• 14 June 2004 report on Progress in relation to the Implementation Plans on Demand and Supply Reduction of Drugs and the Supply of Synthetic Drugs
• 12 November 2003 Communication from the Commission on coordination on drugs in the European Union
• 04 November 2002 Communication from the Commission on the mid-term evaluation of the EU Action Plan on Drugs (2000-2004)
• 08 June 2001 Communication from the Commission on the implementation of the EU Action Plan on Drugs (2000-2004)
• 16 November 2000 Report from the Commission called for by the Joint Action on New Synthetic Drugs (97/396/JAI) concerning Ketamine and GHB
• 26 May 1999 Communication from the Commission on a European Action Plan to Combat Drugs (2000-2004)(5 MB)  
• 23 May 1997 Communication from the Commission on the control of new synthetic drugs (designer drugs)
• 23 June 1994 Communication from the Commission on a European Union action plan to combat drugs (1995-1999)
• 21 June 1994 Communication from the Commission - Community action in the field of drug dependence